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In 2012, the Ministry of Public Health in Lebanon piloted a service of multifactorial cardiovascular screening in the 
publicly subsidized Primary Health Care (PHC) Network. We present an epidemiological analysis of data produced 
during this pilot to justify the inclusion of this service in the package of essential services offered through PHC and to 
present a preliminary cardiovascular risk profile in an asymptomatic population.
Methods
A total of 4,205 participants (two-thirds of which were women) aged at least 40 years and reportedly free from 
diabetes, hypertension, dyslipidemia, and cardiovascular disease (CVD) were screened. The screening protocol used a 
questionnaire and direct measurements to assess 5 modifiable cardiovascular risk factors; total cardiovascular risk 
score was calculated according to a paper-based algorithm developed by the World Health Organization and the 
International Society of Hypertension.
Results
Approximately 25% of the sample displayed metabolic impairments (11% for impaired blood glucose metabolism and 
17% for impaired systolic blood pressure), and 6.6% were classified at total cardiovascular risk of 10% or more. Just 
over one-quarter of the sample was obese, almost half had a substantially elevated waist circumference, and 41% were 
smokers. Men were significantly more likely to screen positive for metabolic impairment than women, and women 
were more likely to be obese.
Conclusion
The implementation of a multifactorial screening for CVD among asymptomatic subjects detected a substantial 
proportion of previously undiagnosed cases of high metabolic risk, people who could now be referred to optimal 
medical follow-up.
Introduction
Lebanon has achieved its epidemiologic transition during the last 2 decades. Noncommunicable diseases became the 
leading cause of illness and death in Lebanon, accounting for 84% of all deaths in 2010 (1). Cardiovascular diseases 
(CVDs) alone account for almost half of all annual deaths in the country (2). Multiple factors contribute to CVD 
pathogenesis. Although some factors, such as age, male sex, and genetic predisposition to atherosclerotic disease, are 
nonmodifiable, others, such as tobacco use, poor weight control, alcohol abuse, hypertension, diabetes, and 
dyslipidemia, are amenable to modification and control (3).
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Lebanon has a high prevalence of modifiable cardiovascular risk factors. For example, 54.6% of the population aged 25 
to 65 are smokers (4). Self-reported diabetes has been estimated at 11% in 2008 (4), and hypertension has increased 
almost threefold in 1 decade (4,5).
Cardiovascular events are the clinical expression of atherosclerotic disease in major end organs, such as the heart 
(myocardial infarction) and brain (stroke) (6). The likelihood that someone will develop a fatal or nonfatal 
cardiovascular event depends on a combination of risk factors rather than on the presence of any single risk factor (7). 
Risk factors for CVD can be compiled in algorithms able to predict an individual’s total cardiovascular risk (TCVR) in a 
given period (8). The World Health Organization (WHO) in partnership with the International Society of Hypertension 
(ISH) developed charts adapted to the Eastern Mediterranean Region populations. The simplified version of the 
WHO/ISH charts does not include dyslipidemia and permits the stratification of 3 risk factors: systolic blood pressure 
(SBP), glucose metabolism, and smoking status, in addition to age and sex, to quantify a total 10-year cardiovascular 
risk score (9,10). The advantage of using these charts is the simplicity of their use and their low cost (11).
The Ministry of Public Health (MOPH) in Lebanon subsidizes secondary and tertiary health care for uninsured citizens 
in an effort to provide universal health coverage (12), although budgets allocated for preventive measures remain 
scarce and irregular (13). This approach of health governance contributed to a culture of overuse of advanced medical 
care (14) while the early detection of risk factors remains insufficient (15). This situation is illustrated by the 
considerable proportion of adults who have never had any blood glucose or blood pressure measurements (4), a 
situation that MOPH is trying to modify.
A pilot project was subsidized in the second half of 2012 to implement a standardized screening protocol for Primary 
Health Care Network (PHC) users without CVD for 5 cardiovascular risk factors and to estimate their TCVR using 
simplified WHO/ISH charts (16). The goal was to reach presumably healthy individuals, empower them with 
knowledge of their cardiovascular risk, and motivate them to seek medical attention and to choose measures to reduce 
that risk. We present an epidemiological analysis of data produced during this pilot phase to assess the usefulness of 
integrating the protocol in the routine services provided by PHC and to present a preliminary cardiovascular risk 
profile in an average healthy population.
Methods
Participants
The pilot project obtained data from a convenience sample of beneficiaries at 25 accredited PHC centers distributed 
across all Lebanese governorates (mohafazats), over 14 weeks during 2012 and 2013. Participants were recruited while 
present at the PHC centers (60% of participants) or through outreach visits to households in the PHC’s catchment area 
(40% of participants). Participants received clear information regarding the aims and objectives of the protocol and 
consented to be screened. They provided permission to use their answers and test results in anonymous analysis.
A total of 5,875 beneficiaries were screened. Records of only 4,205 were retained for analysis after excluding 1,279 
(21.8%) cases previously diagnosed with diabetes, hypertension, dyslipidemia, or CVD. Records from 44 (0.7%) 
beneficiaries were excluded due to missing data on medical background, and 347 (5.9%) because of being younger than 
40.
Variables
Demographic and socioeconomic variables
Data for place of residence (urban or rural and mohafazat) were assimilated to the location of each health center. Data 
for employment status were self-reported and dichotomized into “involved in paid activity” full or part time and “not 
involved in paid activity” (including housewives and retired and unemployed persons). Data on educational level were 
also self-reported, and respondents were divided into 3 categories: illiterate, intermediate (those that had some 
schooling but not reaching the intermediate school exam), or secondary or higher. Beneficiaries of the pilot project 
were grouped into 4 age groups: 40 to 49, 50 to 59, 60 to 69, and 70 or older. Sex was designated as either male or 
female.
Cardiovascular risk factors
Risk factors measured in this project were those used for the WHO/ISH simplified risk score and others with a 
substantial contribution to CVD risk. Respondents were distributed into 5 categories of smoking: 1) occasional: at least 
1 cigarette per day or at least 1 narghileh head per week or both, 2) current (daily) smokers, 3) quitters (within the last 
year), 4) ex-smokers (quit at least 1 year before the study), and 5) never smokers. This variable was further 
dichotomized into smokers, which included the first 3 categories, and nonsmokers, which included the last 2 
categories. 
Random blood glucose (RBS) was measured using the OneTouch Select standardized finger-meter (LifeScan, Inc, 
Milpitas, California). Respondents were categorized as having “impaired RBS” (considered as participants with 
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suspected diabetes) or “unimpaired RBS,” according to cutoff points that take into consideration the time of last meal, 
developed by the National Diabetes Program in Lebanon on the basis of International Diabetes Federation (IDF) 
guidelines and WHO recommendations (17,18). Beneficiaries with fasting blood glucose higher than 110 mg/dL, those 
with a blood glucose level higher than 125 mg/dL at least 2 hours after their last meal, and those with a blood glucose 
level higher than 135 mg/dL within 2 hours of their last meal were classified as having impaired blood glucose 
metabolism. 
SBP was measured on the right arm, over clothing, using standardized digital sphygmomanometers (Omron 
Healthcare, Hamburg, Germany). When a first measurement was abnormal, it was repeated later during the procedure 
and the lowest result was retained. Respondents were categorized as having impaired SBP if SBP was 135 mm Hg or 
more, according to the recommendations issued by MOPH. Participants’ body mass index (BMI) was grouped into 4 
categories, according to WHO’s classification (19): less than 18.5 kg/m (underweight), 18.5 to 24.9 kg/m (normal 
weight), 25.0 to 29.9 kg/m (overweight), and 30.0 kg/m or higher (obese). Waist circumference (WC) was measured 
midway between the lower rib margin and the iliac crest with a regular tailor tape. According to the measurement, 
respondents were grouped into 3 categories: normal, elevated, and substantially elevated WC (SEWC). This 
categorization followed sex-specific cut-off points suggested by WHO and IDF: elevated WC indexed as a waistline 
measurement of 94 cm or more for men and 80 cm or more for women, and SEWC indexed as a waistline 
measurement of 102 cm or more for men and 88 cm or more for women (19).
Total cardiovascular risk stratification
Impaired RBS, smoking status, and SBP scores were compiled by age and sex on the simplified WHO/ISH charts (10) 
to assign each screened participant a corresponding 10-year TCVR score category (Appendix). The compilation results 
were grouped in 5 predefined 10-year cardiovascular risk levels: less than 10% (lowest risk), 10% to less than 20%, 20% 
to less than 30%, 30% to less than 40%, and 40% or more (highest risk). The upper 3 risk categories were consolidated 
in the analysis because of small numbers. Sex, age, smoking status, impaired RBS, SBP, and BMI were also compiled 
on the Framingham online risk calculator using BMI instead of the lipid profile to project the 10-year mean risk of 
CVD (representing the 10-year incidence of CVD) (20,21).
Procedures
After completing the structured questionnaire and undergoing measurements, beneficiaries of the pilot project were 
assigned a score on the WHO/ISH cardiovascular risk charts. Those with TCVR of 10% or more or with impaired SBP 
or impaired RBS or both were classified as “CV/metabolic risk.” These beneficiaries were invited to undergo further 
medical investigations including a lipid profile test and verification of abnormal screening results. The referral was 
usually made to the same health centers where normal though low fees had to be charged. Those who were 
metabolically unimpaired but were obese (BMI of 30.0 kg/m or more or SEWC) were advised to check their lipid 
profile, and smokers were given the option to undergo smoking cessation treatment.
Data management and analysis
Trained health workers entered all data using a software developed for this purpose at MOPH-PHC. The data set was 
later read and analyzed using SPSS version 20 (IBM Corporation). Results were presented as frequencies and 
percentages. We used z tests and χ tests to assess associations in cross-tabulations. Significant associations were those 
with tests leading to a P value ≤. 05. 
Results
Sociodemographic characteristics
Of the 4,205 beneficiaries recruited in the pilot project, 59% were recruited from the PHC centers and the rest during 
household outreach from those centers (Table 1). Women represented almost two-thirds of the group; they had a mean 
age of 51 years, and almost 4 of 5 reported not being in the labor force. Men had a mean age of 52 years, and more than 
80% were involved in paid activity. Approximately 13% of the group were illiterate, more than 25% reached at least 
secondary education, and the remainder had some schooling that did not exceed the 9th grade. Because of the 
predominance of women in the group and some significant differences between men and women found across several 
socioeconomic and demographic variables, all analyses were sex-stratified.
Prevalence of cardiovascular risk factors
The prevalence of smoking was 41% among respondents with a significant difference between men (47%) and women 
(38%; P < .001) (Table 2). Among smokers, 80.3% preferred cigarettes, 17.2% smoked narghileh only, and 1.6% 
smoked both cigarettes and narghileh (data not shown). More than 10% of beneficiaries (n = 457) screened positive for 
impaired RBS; more men (12.2%) than women (10.2%) had impaired RBS (P = .04). More than 15% of the participants 
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More than a quarter of respondents (27.5%) were obese, and almost half of the respondents had a SEWC. Significantly 
more women (58.2%) than men (30.0%) had a SEWC (P < .001).
Total cardiovascular risk
Of all beneficiaries from the screening protocol, 277 (6.6%) scored 10% or above for the TCVR score (Table 3); 9.7% of 
men (n = 138) and 4.8% of women (n = 139) (P < .01). To illustrate the potential effect of early cardiovascular risk-
lowering management on the incidence of cardiovascular events, the sample’s characteristics were plotted using the 
Framingham risk calculators with BMI (Figure), modeling 2 situations. Model 1 represents the scores obtained by 
plotting the actual screening characteristics of the sample, and model 2 represents the hypothetical scores of the same 
sample after simulating the results of risk-lowering therapy on the 3 risk factors: 1) controlled blood pressure (SBP 
=120 mm Hg for those who scored higher), 2) a normal BMI (= 24.9 kg/m for those who were overweight or obese), 
and 3) a nonsmoking status (for those who reported being smokers). The projected risk was inferior to the actual risk 
by 35% in men and 41% in women.
Figure. The means of 10-year general cardiovascular disease (CVD) risk scores calculated by using the Framingham 
equation (20,21) with body mass index (model 1), and Model 1 plus modified risk factors (smoking, systolic blood 
pressure, and body mass index) (model 2), by age and sex. [A tabular version of this figure is also available.]
Cardiovascular risk score
According to screening results and TCVR scores by the WHO/ISH charts, 1,035 (25%) beneficiaries of the pilot project 
were referred to the diagnostic step. Of those, 277 (significantly more men than women, P < .001) had cardiovascular 
risk under the WHO/ISH definition with or without metabolic impairments; 758 had a low TCVR score but had 
impaired RBS, impaired SBP, or both, with an equal male predominance (P < .001).
Of 3,170 beneficiaries (75%) not eligible for referral, 1,536 were obese (SEWC or BMI ≥30.0 kg/m ), and 710 were not 
obese but were smokers (Table 4). In the group, 924 (22%) did not present any of the 3 modifiable risk factors 
considered. 
Discussion
This pilot project used a simplified algorithm for the prediction of TCVR developed by WHO and ISH in 2009 and 
2010 (9). WHO has encouraged individual countries to use this tool to identify patients who would benefit from 
medical attention to deal with their cardiovascular health (11). This injunction corresponded to a desire in Lebanon to 
implement a comprehensive CVD screening strategy focused on early detection of several cardiovascular risk factors in 
1 procedure. The simplicity and the low-cost implementation of the charts were further incentives to use them as a 
mass screening tool. The running cost of the procedure did not exceed $0.50 per patient screened in the facility and $1 
per patient screened in outreach. This inexpensive implementation was due to the voluntary contribution of 
nonphysician health workers employed at the centers of the PHC. The efficiency of this action in detecting a large 
number of potentially modifiable CVD risks in previously asymptomatic individuals was unequivocal, with 1 in 4 
people detected for probable metabolic impairment and referred for further steps. The most important anticipated 
2
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benefit from including such a protocol and implementing adequate follow-up for detected cases would be the decrease 
of CVD incidence, as demonstrated by the projection of the data using the Framingham algorithm.
PHC centers are more popular in rural areas than in urban areas. They attract beneficiaries from lower socioeconomic 
strata and are predominantly used by women. The sex distribution of the study population duplicates the sex 
distribution of PHC users in Lebanon (unpublished internal document of PHC, 2012). The greater use of centers by 
unemployed women may be partially caused by their availability during the morning hours when PHC centers are 
open. This observation calls for the modification of the hours that the PHC center is open to better accommodate 
working men (and women).
The proportion of people of lower socioeconomic status, as indicated by lower educational achievement (75%), was 
higher than the latest national figures for the same age groups (45%), reported in 2011 (22). The overrepresentation of 
less affluent people in the study’s population may have biased the findings, although it is not possible in the present 
phase of sociological transition in Lebanon to estimate whether the bias will be toward over- or under-estimating CVD 
risks for the entire population.
Men were more likely to be referred for metabolic impairment, which does not differ from global patterns of CVD (23). 
Women were more likely to have metabolically unimpaired obesity, reflecting the larger prevalence of obesity among 
women in the Middle East (24). The cutoff values for BMI and WC that were used may not be adapted for the Lebanese 
population, so the issue of defining optimal cutoff points and selecting the best obesity index to use should be 
addressed in forthcoming research.
The findings on RBS screening corroborate Lebanese national (25) and global (26) statistics, showing that diabetes is 
more likely to occur among men than women. However, the prevalence of hypertension among men and women is 
lower than that reported in national representative surveys conducted in 2005 (27) and 2008 (4) and the sex 
differential is larger. This particularity occurring over a short period is likely to be an artifact. 
The proportion of patients with moderate and high TCVR was less than that projected by WHO for the same age 
groups in the geographic subregion in which Lebanon is classified (6). This discrepancy is probably due to the 
inclusion in WHO projections of previously diagnosed metabolically impaired patients, a category that was excluded 
from our analysis. A better benchmark would be a comparison of figures from a more limited area in the region, 
emanating from interventions on apparently healthy people and using a similar procedure. Colleagues from Oman 
undertook a similar screening project but used different cutoff points for raised fasting blood glucose (≥100 mg/dL) 
and hypertension (≥130 mm Hg/≥85 mm Hg) (28). To make the comparison valid, we reclassified our patients 
according to fasting blood glucose and hypertension by using the same criteria used by the Omani colleagues and 
found comparable rates of positive screening results for both measurements (Table 5). However, the equivalence of 
findings resulting from the screening interventions cannot guarantee equality in overall prevalence of diabetes and 
hypertension in those 2 countries, nor does it eliminate the need for population-based prevalence surveys or 
continuous surveillance in Lebanon.
Several countries in the region engaged in successful implementation of CVD prevention on the basis of early detection 
of multiple cardiovascular risk factors, for example in Kuwait (29) and in Oman (28). However, Lebanon is so far the 
first country in the region to test and report on the implementation of TCVR score estimation with mass screenings 
conducted by nonphysician health workers inside PHC facilities and through outreach to beneficiaries’ homes. The 
added value of such an approach is dual. First, it maximizes the predictive value of the CVD screening by optimizing 
several easily and economically measurable cardiovascular risk factors (30). Second, using the risk stratification 
approach as an indicator rather than emphasizing results of each individual cardiovascular risk factor will help 
improve the awareness of health workers and beneficiaries on the joint adverse effects of clustering cardiovascular risk 
factors on cardiovascular health, and the importance of addressing all of them as a package (6–8).
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Tables
Table 1. Sociodemographic Characteristics of Participants (N = 4,205) in a 





Male — — 1,422 (33.8)
Female — — 2,783 (66.2)
Age, y
40–49 689 (48.5)* 1,556 (55.9) 2,245 (53.4)
50–59 430 (30.2)* 763 (27.4) 1,193 (28.4)
60–69 193 (13.6)* 303 (10.9) 496 (11.8)
≥70 110 (7.7)* 161 (5.8) 271 (6.4)
Mean age, y (SD) 52.2 (9.8) 50.8 (9.3) 51.3 (9.5)
Work status (N = 4,174)
Involved in paid activity 1,180 (83.7)* 601 (21.7) 1,781 (42.7)
Not involved in paid work 230 (16.3)* 2,163 (78.3) 2,393 (57.3)
Education (N = 4,069)
Illiterate 139 (10.0)* 393 (14.7)* 532 (13.1)
Up to intermediate 881 (63.5)* 1,616 (60.3) 2,497 (61.4)
















In Primary Health Care Network facility 809 (56.9)* 1,679 (60.3) 2,488 (59.2)
Household outreach 613 (43.1)* 1,104 (39.7) 1,717 (40.8)
Residence, by centers’ location
Rural 864 (60.8)* 1,575 (56.6) 2,439 (58.0)
Urban/suburban 558 (39.2)* 1,208 (43.4) 1,766 (42.0)
Mohafazat, by centers’ location
Beirut 134 (9.4)* 278 (10.0)* 412 (9.8)
Beirut suburb 115 (8.1)* 348 (12.5) 463 (11.0)
Mont Lebanon 146 (10.3)* 225 (8.1) 371 (8.8)
North Lebanon 295 (20.7)* 564 (20.3)* 859 (20.4)
South Lebanon 370 (26.0)* 724 (26.0)* 1,094 (26.0)
Nabatieh 167 (11.7)* 350 (12.6)* 517 (12.3)
Beqaa 195 (13.7)* 294 (10.6) 489 (11.6)
Values may not sum to 4,205 because of missing data.
Data with different symbols (*, †) in columns of the same row denote significant difference in proportions between men 
and women; significance set at P ≤ .05 and calculated using z test.
Table 2. Prevalence of Cardiovascular Risk Factors Among Participants in a 
Cardiovascular Screening Pilot Phase in Lebanon, 2012–2013
Variable
Men (n = 
1,422)
Women (n = 
2,783)





Never smoked 680 (47.8) 1,652 (59.4) 2,332 (55.5) <.001 
Ex-smokers 74 (5.2) 80 (2.9) 154 (3.7) <.001
Smokers and those who quit within the last 
year 
668 (47.0) 1,051 (37.8) 1,719 (40.9) <.001
Random blood glucose
Unimpaired 1,248 (87.8) 2,500 (89.8) 3,748 (89.1) .04
Impaired 174 (12.2) 283 (10.2) 457 (10.9)
Systolic blood pressure
Unimpaired 1,094 (76.9) 2,412 (86.7) 3,506 (83.4) <.001
Impaired 328 (23.1) 371 (13.3) 699 (16.6)
Body mass index, kg/m
<25.0 419 (29.5) 913 (32.8) 1,332 (31.7) .03
25.0–29.9 623 (43.8) 1,092 (39.2) 1,715 (40.8) .004
≥30 380 (26.7) 778 (28.0) 1,158 (27.5) .40
Waist circumference
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Variable
Men (n = 
1,422)
Women (n = 
2,783)




Elevated 433 (30.5) 675 (24.3) 1,108 (26.3) <.001
Substantially elevated 426 (30.0) 1,621 (58.2) 2,047 (48.7) <.001
Abbreviation: WC, waist circumference.
P values calculated using χ test for dichotomous variables and using z test for variables with more than 2 categories.
Participants with fasting blood glucose higher than 110 mg/dL, those with a blood glucose level higher than 125 mg/dL at 
least 2 hours after their last meal, and those with blood glucose level higher than 135 mg/dL within 2 hours of their last 
meal were classified as having impaired blood glucose metabolism.
Participants were categorized as having impaired systolic blood pressure if pressure was 135 mm Hg or more.
Table 3. Distribution of Beneficiaries (N = 4,205), by Cardiovascular Risk 
Scores, Paticipants in a Cardiovascular Screening Pilot Phase in Lebanon, 
2012–2013
Sex/Age, y
Low TCVR Score, WHO/ISH 
Score <10%
Moderate TCVR Score, WHO/ISH 
Score 10% to <20%
High TCVR Score, 
WHO/ISH Score ≥20%
n (%) WHO n (%) WHO n (%) WHO
Men (n = 1,422)
40–49 686 (99.6) 99.1 2 (0.3) 0.7 1 (0.1) 0.2
50–59 413 (96.0) 83.9 9 (2.1) 7.8 8 (1.9) 8.3
60–69 145 (75.1) 34.6 33 (17.1) 28.5 15 (7.8) 27.9
≥70 40 (36.4) 8.6 48 (43.6) 34.2 22 (20.0) 57.2
Total men 1,284 (90.3) NA 92 (6.5) NA 46 (3.2) NA
Women (n = 2,783)
40–49 1,552 (99.7) 99.2 3 (0.2) 0.5 1 (0.1) 0.2
50–59 746 (97.8) 81.7 12 (1.6) 9.2 5 (0.7) 9.1
60–69 239 (78.9) 24.3 54 (17.8) 32.0 10 (3.3) 43.7
≥70 107 (66.5) 2.8 31 (19.3) 29.5 23 (14.3) 67.7
Total women 2,644 (95.0) NA 100 (3.6) NA 39 (1.4) NA
Total (N = 4,205)
40–49 2,238 (99.7) NA 5 (0.2) NA 2 (0.1) NA
50–59 1,159 (97.2) NA 21 (1.8) NA 13 (1.1) NA
60–69 384 (77.4) NA 87 (17.5) NA 25 (5.0) NA
≥70 147 (54.2) NA 79 (29.2) NA 45 (16.6) NA
Total both 
sexes
3,928 (93.4) NA 192 (4.6) NA 85 (2.0) NA
Abbreviations: TCVR, total cardiovascular risk; WHO/ISH, World Health Organization/International Society of Hypertension; 
NA, not applicable.
Men were significantly more likely to score 10% and above for TCVR (9.3% of men vs 5.2% of women, P < .001).
TCVR assessed using simplified WHO/ISH charts (9,10).
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Table 4. Distribution of the Sample (N = 4,205), by Results of 
Screening and Eligibility for Referral to Follow-Up Steps, 
Participants in a Cardiovascular Screening Pilot Phase in Lebanon, 2012–2013
Cardiovascular Risk Groups
Men (n = 1,422), n 
(%)
Women (n = 2,783) , n 
(%)
Total (N = 4,205) , n 
(%)
Referred to diagnostic step 464 (32.6) 571 (20.5) 1,035 (24.6)
TCVR ≥10% and metabolic impairment 112 (7.9) 139 (5.0) 251 (6.0)
Only TCVR score ≥10% 26 (1.8) 0 26 (0.6)
Only metabolic impairment 326 (22.9) 432 (15.5) 758 (18.0)
Not referred to diagnostic step 958 (67.4) 2,212 (79.5) 3,170 (75.4)
Metabolically unimpaired obese 306 (21.5) 1,230 (44.2) 1,536 (36.5)
Nonobese, metabolically unimpaired 
smokers
317 (22.3) 393 (14.1) 710 (16.9)
No risk factors detected 335 (23.6) 589 (21.2) 924 (22.0)
Abbreviation: TCVR, total cardiovascular risk.
Indexed as body mass index ≥30 or substantially elevated waist circumference (waistline ≥94 cm in men and ≥88 cm in 
women) or both.
Table 5. Comparison of Findings of Pilot Project in Lebanon (2012) and the 
Pilot Screening in Oman (2008)
Country/Sex
Hypertension (≥130/85 mm Hg) Raised FBS (≥100 mg/dL)
No. Screened (% With Condition)
Oman
Men 6,869 (36) 6,869 (44)
Women 11,043 (32) 11,043 (41)
Total 17,912 (33) 17,912 (42)
Lebanon
Men 1,422 (43) 535 (44)
Women 2,783 (32) 1,006 (40)
Total 4,205 (36) 1,541(42)
Abbreviation: FBS, fasting blood glucose.
Omani results from the Operational and Management Guidelines for the National Noncommunicable Disease Screening 
Program (28).
Appendix. World Health Organization/International 
Society of Hypertension (WHO/ISH) Risk Prediction 
Chart for EMR B Region, Displaying the 10-Year Risk Score of a 
Fatal or Nonfatal Cardiovascular Event (10)
Age, y
Men, % Women, %
Systolic Blood Pressure, mm HgNonsmoker Smoker Nonsmoker Smoker
EMR B People With Diabetes Mellitus
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Age, y
Men, % Women, %
Systolic Blood Pressure, mm HgNonsmoker Smoker Nonsmoker Smoker
≥40 ≥40 ≥40 ≥40 160
20 to <30 ≥40 30 to <40 ≥40 140
10 to <20 20 to <30 10 to <20 20 to <30 120
60 ≥40 ≥40 ≥40 ≥40 180
30 to <40 ≥40 30 to <40 ≥40 160
10 to <20 20 to <30 10 to <20 30 to <40 140
<10 10 to <20 10 to <20 10 to <20 120
50 30 to <40 ≥40 ≥40 ≥40 180
10 to <20 20 to <30 10 to <20 20 to <30 160
<10 <10 <10 10 to <20 140
<10 <10 <10 <10 120
40 10 to <20 30 to <40 10 to <20 20 to <30 180
<10 <10 <10 <10 160
<10 <10 <10 <10 140
<10 <10 <10 <10 120
EMR B People Without Diabetes Mellitus
70 ≥40 ≥40 ≥40 ≥40 180
20 to <30 30 to <40 20 to <30 30 to <40 160
10 to <20 20 to <30 10 to <20 20 to <30 140
<10 10 to <20 <10 10 to <20 120
60 ≥40 ≥40 30 to <40 ≥40 180
10 to <20 20 to <30 10 to <20 20 to <30 160
<10 10 to <20 <10 10 to <20 140
<10 <10 <10 <10 120
50 20 to <30 ≥40 20 to <30 ≥40 180
<10 10 to <20 <10 10 to <20 160
<10 <10 <10 <10 140
<10 <10 <10 <10 120
40 10 to <20 20 to <30 <10 10 to <20 180
<10 <10 <10 <10 160
<10 <10 <10 <10 140
<10 <10 <10 <10 120
Abbreviation: EMR B, WHO Eastern Mediterranean Region, subregion B.
This chart can be used only for countries of the EMR B: Bahrain, Iran (Islamic Republic of), Jordan, Kuwait, Lebanon, 
Libya, Oman, Saudi Arabia, Syrian Arab Republic, Tunisia, and United Arab Emirates.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. 
Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, 
or the authors' affiliated institutions.
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